Read + Share
Chang LS, Oblinger JL, Smith AE, Ferrer M, et al. Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma
through inhibition of multiple tyrosine kinases but not ALK. PLoS One 2021;16:e0252048.
PMID: 34264955
|
 |
|
Chang LS, Oblinger JL, Smith AE, Ferrer M, et al. Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma
through inhibition of multiple tyrosine kinases but not ALK. PLoS One 2021;16:e0252048.
PMID: 34264955
|
|
|
|